HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its legal challenge to the process.
Voluntariness was a key factor …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
EQS-News: Heidelberg Pharma AG / Key word(s): Patent Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform 15.11.2023 / 09:24 CET/CEST The
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: A study of Boston Scientific’s
Amid the many demands of practicing medicine, doctors can have less time and energy for their patients, and those relationships can suffer. Yet research has